दवाओं की अंतःक्रिया
Deferiprone + Trastuzumab deruxtecan
गंभीरता: गंभीर
Deferiprone and Trastuzumab deruxtecan: major interaction.
अंतिम अपडेट
केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।
इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।
सारांश
Deferiprone can cause neutropenia and agranulocytosis, and trastuzumab deruxtecan is also associated with neutropenia. Used together, the risk of severe myelosuppression and serious infection is higher.
इस इंटरैक्शन का सरल भाषा में अर्थ
Deferiprone and Trastuzumab deruxtecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Deferiprone belongs to Miscellaneous; Trastuzumab deruxtecan belongs to Oncology.
ऐसा क्यों होता है
Additive pharmacodynamic myelosuppression affecting neutrophil counts.
क्या करें
Avoid the combination where an alternative exists. If both are needed, check absolute neutrophil count more often than usual and interrupt deferiprone if neutropenia develops.
फार्मासिस्ट से क्या पूछें
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ सदस्यों के लिए
पूरा पेज खोलें
Deferiprone और Trastuzumab deruxtecan की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।
Deferiprone के अन्य इंटरैक्शन
Trastuzumab deruxtecan के अन्य इंटरैक्शन
अक्सर पूछे जाने वाले प्रश्न
Can I take Deferiprone with Trastuzumab deruxtecan?
MediHelp rates the interaction as major. Deferiprone and Trastuzumab deruxtecan can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Deferiprone can cause neutropenia and agranulocytosis, and trastuzumab deruxtecan is also associated with neutropenia. Used together, the risk of severe myelosuppression and serious infection is higher.
How serious is the interaction between Deferiprone and Trastuzumab deruxtecan?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where an alternative exists. If both are needed, check absolute neutrophil count more often than usual and interrupt deferiprone if neutropenia develops.
What other medicines interact with Deferiprone?
MediHelp also lists interactions of Deferiprone with, for example, Clozapine, Abemaciclib, Acalabrutinib. The full list is on the Deferiprone page.
MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर
MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।
